Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "precision-oncology"

65 News Found

MedGenome documentary highlights role of genomics in personalized cancer care
News | June 12, 2026

MedGenome documentary highlights role of genomics in personalized cancer care

The film tells the story of a 70-year-old woman from Kota, Rajasthan, whose persistent cough led to a diagnosis of advanced lung cancer


GSK bets big on oncology with $10.6 billion Nuvalent acquisition
News | June 10, 2026

GSK bets big on oncology with $10.6 billion Nuvalent acquisition

Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio


Agilus’s Idylla claims to deliver cancer mutation results in just 3 hours
Healthcare | June 09, 2026

Agilus’s Idylla claims to deliver cancer mutation results in just 3 hours

Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology


Abbott highlights prognostic value of MRD testing for breast cancer recurrence
Clinical Trials | June 03, 2026

Abbott highlights prognostic value of MRD testing for breast cancer recurrence

New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients


AstraZeneca breast cancer drug wins key EU backing after cutting progression risk by 56%
Clinical Trials | May 25, 2026

AstraZeneca breast cancer drug wins key EU backing after cutting progression risk by 56%

The recommendation is powered by blockbuster results from the pivotal Phase III SERENA-6 trial


HCG launches advanced cancer hospital in Karnataka
Hospitals | May 20, 2026

HCG launches advanced cancer hospital in Karnataka

The new facility at Byatarayanapura introduces Karnataka’s first Elekta Unity MR-Linac technology


Strand Life launches advanced proteomics capabilities
Biopharma | May 19, 2026

Strand Life launches advanced proteomics capabilities

The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample


Roche Pharma launches India’s first subcutaneous immunotherapy for lung cancer
Biopharma | May 19, 2026

Roche Pharma launches India’s first subcutaneous immunotherapy for lung cancer

Tecentriq SC reduces treatment administration time by nearly 80 percent and has the potential to lower indirect treatment costs


Roche moves to acquire PathAI for up to $1.05 billion in major AI pathology push
News | May 08, 2026

Roche moves to acquire PathAI for up to $1.05 billion in major AI pathology push

The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities


Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy
Biopharma | April 29, 2026

Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy

Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights